Blood lipoproteins. Disorders of lipoprotein metabolism and other lipidaemias
Conditions
Interventions
Intervention 1: L-Carnitine, 250 mgTablets, 13 mg per each kilogram of their body weight, sex-weeks. taking l-carnitine supplement 1 day after the last consumption of l-carnitine blood sampling was co
Treatment - Drugs
Placebo
L-Carnitine, 250 mgTablets, 13 mg per each kilogram of their body weight, sex-weeks. taking l-carnitine supplement 1 day after the last consumption of l-carnitine blood sampling was conducted
placebo: starch, Tablets 250mg, 3mg,3 mg of starch per each kilogram of their body weight. Six- weeks. taking the placebo last 1 day after taking the placebo was conducted blood sampling
Sponsors
Institute of strategic studies of the Ministry of youth and sports
Eligibility
Sex/Gender
Male
Age
19 Years to 22 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: the subjects are non-athlete, with age range 19 -22 years old; subjects weight 65-75 Kg; not having any cardiovascular, pulmonary, musculature, problems. Exclusion criterion: the lack of the presence of more than one session of exercise.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body fat percentage. Timepoint: 24 before and after training. Method of measurement: mm, Caliper harpanden. | — |
Secondary
| Measure | Time frame |
|---|---|
| Lipid Profile. Timepoint: 24 before and after training. Method of measurement: mg/dl, auto analyzer BT3000. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarzad nobakht
University of Mohaghegh Ardabili
Outcome results
None listed